retatrutide weight loss clinical trial results Treatment Explained 💉 Retatrutide may be redefining

ERK, Extracellular Signal-Regulated Kinase

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Key takeaways Ozempic (semaglutide), a diabetes medication, shows promise in improving PCOS symptoms by promoting weight loss and enhancing insulin sensitivity

As outlined in this guide, these treatments differ in formulation, dosing, and appetite-regulating strength, which is why successful outcomes depend on careful selection, structured follow-up, and realistic expectations rather than on medication names alone

GLP-1 receptor agonists in the treatment of type 2 diabetesstate-of-the-art

Given the recent evidence for kidney benefits, GLP1-RA should also be considered for patients with T2D and CKD, especially those at higher risk for ASCVD